BAP Stock Analysis: Credicorp | NYSE
Banks - Regional | NYSE, USA | Market Cap: 29.912m USD | 12M Return: 82.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 198M
EPS Trend: 91.5%
Qual. Beats: 0
Rev. Trend: 88.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: under 40 is mostly noise, over 50 gets interesting, and over 70 is strong.
Credicorp Ltd. (NYSE: BAP) is a Lima, Peru-based financial holding company founded in 1889 that operates across Peru, Bermuda, Colombia, Bolivia, Panama, Chile, the United States, the Cayman Islands, and Mexico. It runs four business segments: Universal Banking; Insurance, Medical Services, and Pensions; Microfinance; and Investment Management and Advisory. Its activities span credit and deposit products for individuals and legal entities, insurance underwriting (commercial property, transport, marine, automotive, life, health, and pensions), private pension fund administration, brokerage and investment management for institutional and corporate clients, capital markets and securitization services, custody and trustee services, asset management, payment processing, and digital commerce platforms.
As a Diversified Bank within the GICS Financials sector, Credicorp combines traditional commercial banking with insurance, pensions, and microfinance under a universal banking model. Listed on the NYSE since 1995, it is considered the largest financial group in Peru, with a presence that extends across much of the Andean and broader Latin American region.
- Peru central bank rate cuts compress net interest margin
- Universal Banking loan growth drives segment revenue
- Insurance and pension AUM growth lifts fee income
| Net Income: 7.20b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -2.80 > 1.0 |
| NWC/Revenue: 116.8% < 20% (prev -322.1%; Δ 438.9% < -1%) |
| CFO/TA 0.03 > 3% & CFO 6.94b > Net Income 7.20b |
| Net Debt (-11.3b) to EBITDA (11.5b): -0.99 < 3 |
| Current Ratio: 3.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.5m) vs 12m ago 0.14% < -2% |
| Gross Margin: 76.71% > 18% (prev 62.17%; Δ 14.54% > 0.5%) |
| Asset Turnover: 10.97% > 50% (prev 10.05%; Δ 0.92% > 0%) |
| Interest Coverage Ratio: 2.18 > 6 (EBIT TTM 10.5b / Interest Expense TTM 4.84b) |
| A: 0.12 (Total Current Assets 45.1b - Total Current Liabilities 11.5b) / Total Assets 270b |
| B: 0.01 (Retained Earnings 2.04b / Total Assets 270b) |
| C: 0.04 (EBIT TTM 10.5b / Avg Total Assets 262b) |
| D: 0.17 (Book Value of Equity 38.8b / Total Liabilities 231b) |
| Altman-Z'' = 1.29 = BB |
| DSRI: 0.13 (Receivables 1.85b/12.3b, Revenue 28.8b/25.5b) |
| GMI: 0.81 (GM 62.17% / 76.71%) |
| AQI: 1.27 (AQ_t 0.82 / AQ_t-1 0.65) |
| SGI: 1.13 (Revenue 28.8b / 25.5b) |
| TATA: 0.00 (NI 7.20b - CFO 6.94b) / TA 270b) |
| Beneish M = -3.66 (Cap -4..+1) = AAA |
As of July 02, 2026, the stock is trading at USD 389.58 with a total of 380,773 shares traded. Over the past week, the price has changed by +2.79%, over one month by +13.64%, over three months by +18.88% and over the past year by +82.22%.
Current recommended Stop Loss: 349.60 (which is 10.3% or 2.6 ATR below the current price).
Credicorp has received a consensus analysts rating of 4.23. Therefore, it is recommended to buy BAP.
- StrongBuy: 7
- Buy: 3
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 386.1 | -0.9% |
P/E Trailing = 14.3479
P/E Forward = 12.6422
P/S = 1.3789
P/B = 2.6146
P/EG = 4.5503
Revenue TTM = 28.8b USD
EBIT TTM = 10.5b USD
EBITDA TTM = 11.5b USD
Long Term Debt = 25.0b USD (from longTermDebt, last quarter)
Short Term Debt = 11.5b USD (from shortTermDebt, last quarter)
Debt = 32.0b USD (from shortLongTermDebtTotal, last quarter) + Leases 612.3m
Net Debt = -11.3b USD (calculated: Debt 32.0b - CCE 43.3b)
Enterprise Value = 18.6b USD (29.9b + Debt 32.0b - CCE 43.3b)
Interest Coverage Ratio = 2.18 (Ebit TTM 10.5b / Interest Expense TTM 4.84b)
EV/FCF = 2.79x (Enterprise Value 18.6b / FCF TTM 6.67b)
FCF Yield = 35.82% (FCF TTM 6.67b / Enterprise Value 18.6b)
FCF Margin = 23.19% (FCF TTM 6.67b / Revenue TTM 28.8b)
Net Margin = 25.03% (Net Income TTM 7.20b / Revenue TTM 28.8b)
Gross Margin = 76.71% ((Revenue TTM 28.8b - Cost of Revenue TTM 6.70b) / Revenue TTM)
Gross Margin QoQ = 77.66% (prev 76.92%)
Tobins Q-Ratio = 0.07 (Enterprise Value 18.6b / Total Assets 270b)
Interest Expense / Debt = 15.12% (Interest Expense 4.84b / Debt 32.0b)
Taxrate = 28.72% (2.96b / 10.3b)
NOPAT = 7.50b (EBIT 10.5b * (1 - 28.72%))
Current Ratio = 3.91 (Total Current Assets 45.1b / Total Current Liabilities 11.5b)
Debt / Equity = 0.83 (Debt 32.0b / totalStockholderEquity, last quarter 38.8b)
Debt / EBITDA = -0.99 (Net Debt -11.3b / EBITDA 11.5b)
Debt / FCF = -1.69 (Net Debt -11.3b / FCF TTM 6.67b)
Total Stockholder Equity = 36.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.75% (Net Income 7.20b / Total Assets 270b)
RoE = 19.66% (Net Income TTM 7.20b / Total Stockholder Equity 36.6b)
RoCE = 17.10% (EBIT 10.5b / Capital Employed (Equity 36.6b + L.T.Debt 25.0b))
RoIC = 2.79% (NOPAT 7.50b / Invested Capital 268b)
WACC = 9.30% (E(29.9b)/V(61.9b) * Re(7.71%) + D(32.0b)/V(61.9b) * Rd(15.12%) * (1-Tc(0.29)))
Discount Rate = 7.71% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 26.97 | Cagr: 0.00%
[DCF] Terminal Value 69.63% ; FCFF base≈9.37b ; Y1≈8.21b ; Y5≈6.64b
[DCF] Fair Price = 1.30k (EV 92.1b - Net Debt -11.3b = Equity 103b / Shares 79.4m; r=9.30% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 91.54 | EPS CAGR: 18.77% | SUE: 0.66 | # QB: 0
Revenue Correlation: 88.24 | Revenue CAGR: 6.74% | SUE: 0.77 | # QB: 0
EPS current Quarter (2026-09-30): EPS=7.47 | Chg30d=-2.25% | Revisions=-43% | Analysts=4
EPS current Year (2026-12-31): EPS=29.59 | Chg30d=+0.70% | Revisions=-9% | GrowthEPS=+14.4% | GrowthRev=+8.2%
EPS next Year (2027-12-31): EPS=33.14 | Chg30d=+0.79% | Revisions=+20% | GrowthEPS=+12.0% | GrowthRev=+10.1%
[Analyst] Revisions Ratio: -43%